RecruitingPediatric CancerSurvivorship
Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer
Eligible age
15–24 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Prior research determined adolescent and young adult-aged childhood cancer survivor (AYA-CCS) and medical provider acceptability of the SexFS Brief in a controlled research setting. Development of an acceptable, effective, and feasible screening approach will result in improved recognition of SD in AYA patients with and surviving childhood cancer.
Sponsor: University of Colorado, Denver
You may qualify if…
- ✓ In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- ✓ 1. Provision to sign and date the consent form.
- ✓ 2. Stated willingness to comply with all study procedures and be available for the duration of the study.
- ✓ 3. Be aged 15-24 years old at the time of enrollment
- ✓ 4. Patients with or surviving of cancer (must be found in the International Classification of Diseases for Oncology (ICD-O) and have a behavior code ≥2)
- ✓ 5. Must have received cancer-directed therapy with at least one of the following:
- ✓ Chemotherapy: any anticancer drug to treat the cancer diagnosis including immunotherapy
- ✓ Radiotherapy: any radiotherapy to treat the cancer diagnosis
You may not qualify if…
- ✕ An individual who meets any of the following criteria will be excluded from participation in this study:
- ✕ 1. Unable to read and speak English
- ✕ 2. Patients who did not receive cancer-directed therapy
- ✕ 3. Insufficient cognitive functioning to complete study measures, as determined by patient's
- ✕ 4. Participation in intervention development
- ✕ 5. Patient is at end of life or on hospice, as determined by primary oncologist
- ✕ 6. Patients who did not undergo sexual function screening within 1 month of being due will be excluded from implementation outcomes measurement
- ✕ 7. Patient is at end of life or on hospice, as determined by primary oncologist
Where it's recruiting
Colorado
Aurora
Source: ClinicalTrials.gov · NCT05524610 · last updated 2026-05-06